NCT05334108 - Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

August 26, 2022

Conditions

Drug Interaction

Interventions

DRUG

Ecopipam

ecopipam HCl \~2mg/kg/day

COMBINATION_PRODUCT

Cohort 1 Probe Substrate Cocktail

dextromethorphan, caffeine, omeprazole, and midazolam

DRUG

Cohort 2 Probe Substrate

bupropion

COMBINATION_PRODUCT

Cohort 3 Probe Substrate Cocktail

dabigatran, pitavastatin, rosuvastatin, atorvastatin, midazolam

Trial Locations (1)

ICON Early Phase Services, San Antonio